James J. McGough

ORCID: 0000-0001-8007-9086
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Attention Deficit Hyperactivity Disorder
  • Bipolar Disorder and Treatment
  • Child and Adolescent Psychosocial and Emotional Development
  • Autism Spectrum Disorder Research
  • Functional Brain Connectivity Studies
  • Neural and Behavioral Psychology Studies
  • Children's Physical and Motor Development
  • Genetics and Neurodevelopmental Disorders
  • Neurotransmitter Receptor Influence on Behavior
  • Behavioral and Psychological Studies
  • Hemispheric Asymmetry in Neuroscience
  • Pharmaceutical studies and practices
  • EEG and Brain-Computer Interfaces
  • Adolescent and Pediatric Healthcare
  • Obsessive-Compulsive Spectrum Disorders
  • Genetic Associations and Epidemiology
  • Vagus Nerve Stimulation Research
  • Neurological disorders and treatments
  • Child Nutrition and Feeding Issues
  • Infant Development and Preterm Care
  • Treatment of Major Depression
  • Prenatal Substance Exposure Effects
  • Health Systems, Economic Evaluations, Quality of Life
  • Health, Environment, Cognitive Aging
  • Childhood Cancer Survivors' Quality of Life

University of California, Los Angeles
2013-2024

Gomel Engineering Institute
2018

Salk Institute for Biological Studies
2018

Neurobehavioral Systems
2000-2014

UCLA Medical Center
2002-2014

Cardiff University
2013

Radboud University Nijmegen
2013

Takeda (United States)
2005-2012

Stone Clinic
2012

University Hospitals Cleveland Medical Center
2012

Atypical antipsychotic agents, which block postsynaptic dopamine and serotonin receptors, have advantages over traditional medications in the treatment of adults with schizophrenia may be beneficial children autistic disorder who serious behavioral disturbances. However, data on safety efficacy atypical agents are limited.

10.1056/nejmoa013171 article EN New England Journal of Medicine 2002-08-01
Phil H. Lee Verneri Anttila Hyejung Won Yen‐Chen Anne Feng Jacob Rosenthal and 95 more Zhaozhong Zhu Elliot M. Tucker‐Drob Michel G. Nivard Andrew D. Grotzinger Daniëlle Posthuma Meg M.-J. Wang Dongmei Yu Eli A. Stahl Raymond K. Walters Richard Anney Laramie E. Duncan Tian Ge Rolf Adolfsson Tobias Banaschewski Síntia Belangero Edwin H. Cook Giovanni Coppola Eske M. Derks Pieter J. Hoekstra Jaakko Kaprio Anna Keski‐Rahkonen George Kirov Henry R. Kranzler Jurjen J. Luykx Luís Augusto Rohde Clement C. Zai Esben Agerbo María J. Arranz Philip Asherson Marie Bækvad‐Hansen Gísli Baldursson Mark A. Bellgrove Richard A. Belliveau Jan K. Buitelaar Christie L. Burton Jonas Bybjerg‐Grauholm Miguel Casas Felecia Cerrato Kimberly Chambert Tracy Air Bru Cormand Jennifer Crosbie Søren Dalsgaard Ditte Demontis Alysa E. Doyle Ashley Dumont Josephine Elia Jakob Grove Ólafur Ó. Guðmundsson Jan Haavik Hákon Hákonarson Christine Søholm Hansen Catharina A. Hartman Ziarih Hawi Amaia Hervás David M. Hougaard Daniel P. Howrigan Hailiang Huang Jonna Kuntsi K. Langley Klaus‐Peter Lesch Patrick W. L. Leung Sandra K. Loo Joanna Martin Alicia R. Martin James J. McGough Sarah E. Medland Jennifer L. Moran Ole Mors Preben Bo Mortensen Robert D. Oades Duncan S. Palmer Carsten Bøcker Pedersen Marianne G. Pedersen Triinu Peters Timothy Poterba Jesper Buchhave Poulsen Josep Antoni Ramos‐Quiroga Andreas Reif Marta Ribasés Aribert Rothenberger Paula Rovira Cristina Sánchez‐Mora F. Kyle Satterstrom Russell Schachar María Soler Artigas Stacy Steinberg Hreinn Stefánsson Patrick Turley G. Bragi Walters Thomas Werge Tetyana Zayats Dan E. Arking Francesco Bettella Joseph D. Buxbaum

10.1016/j.cell.2019.11.020 article EN publisher-specific-oa Cell 2019-12-01

OBJECTIVE: Risperidone has been found efficacious for decreasing severe tantrums, aggression, and self-injurious behavior in children adolescents with autistic disorder (autism). The authors report on whether risperidone improves the core symptoms of autism, social communication impairment repetitive stereotyped behavior. METHOD: database from an 8-week double-blind, placebo-controlled trial (N=101) 16-week open-label continuation study (N=63) autism was used to test drug effects secondary...

10.1176/appi.ajp.162.6.1142 article EN American Journal of Psychiatry 2005-06-01

OBJECTIVE: Patterns of psychiatric comorbidity were assessed in adults with and without attention deficit hyperactivity disorder (ADHD) identified through a genetic study families containing multiple children ADHD. METHOD: Lifetime ADHD comorbid psychopathology 435 parents Rates mean ages at onset compared lifetime ADHD, persistent those Age-adjusted rates Kaplan-Meier survival curves. Logistic regression was used to assess additional risk factors for conditions more frequent subjects....

10.1176/appi.ajp.162.9.1621 article EN American Journal of Psychiatry 2005-08-31

Objective: Short-term, controlled studies of extended-release guanfacine (GXR), a selective α2A-adrenoreceptor agonist, demonstrate efficacy in treating attention-deficit/hyperactivity disorder (ADHD) symptoms as monotherapy. This 2-year open-label study was conducted to further assess the long-term safety and GXR. Methods: Study participants, aged 6–17 years with ADHD, had previously been exposed GXR therapy alone or combination psychostimulants one two antecedent trials. In this study,...

10.1089/cap.2008.0080 article EN Journal of Child and Adolescent Psychopharmacology 2009-06-01

Objective: The aim of this study was to describe the clinical presentation preschoolers diagnosed with moderate severe attention-deficit/hyperactivity disorder (ADHD) recruited for multisite Preschool ADHD Treatment Study (PATS). diagnosis and evaluation process will also be described. Method: A comprehensive multidimensional, multi-informant assessment protocol implemented including semistructured PATS Diagnostic Interview. Parent- teacher-report measures were used supplement information...

10.1089/cap.2007.0075 article EN Journal of Child and Adolescent Psychopharmacology 2007-10-01

In the current study we sought to dissociate component processes of working memory (WM) (vigilance, encoding and maintenance) that may be differentially impaired in attention-deficit/ hyperactivity disorder (ADHD). We collected electroencephalographic (EEG) data from 52 children with ADHD 47 typically developing (TD) children, ages 7-14 years, while they performed a spatial Sternberg task. used independent analysis time-frequency identify midoccipital alpha (8-12 Hz) evaluate frontal midline...

10.1523/jneurosci.1765-13.2014 article EN cc-by-nc-sa Journal of Neuroscience 2014-01-22

OBJECTIVE Although attention deficit hyperactivity disorder (ADHD) is highly heritable, genome-wide association studies (GWAS) have not yet identified any common genetic variants that contribute to risk. There evidence aggression or conduct in children with ADHD indexes higher loading and clinical severity. The authors examine whether considered en masse as polygenic scores for are especially enriched comorbid disorder. METHOD Polygenic derived from an GWAS meta-analysis were calculated...

10.1176/appi.ajp.2013.12081129 article EN American Journal of Psychiatry 2013-07-04
Coming Soon ...